Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas R Bertos

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancerApril A N Rose, Andrée-Anne Grosset, Zhifeng Dong, et al.
Molecular Cell|January 22, 2003
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanismsIsabelle Fernandes, Yolande Bastien, Timothy Wai, et al.
Cell Reports|November 2, 2017
A Targetable EGFR-Dependent Tumor-Initiating Program in Breast CancerPaul Savage, Alexis Blanchet-Cohen, Timothée Revil, et al.
Communications Biology|June 18, 2020
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumorsPaul Savage, Alain Pacis, Hellen Kuasne, et al.
Science Immunology|April 1, 2022
Spatially mapping the immune landscape of melanoma using imaging mass cytometryDan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancerApril A N Rose, Andrée-Anne Grosset, Zhifeng Dong, et al.
Molecular Cell|January 22, 2003
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanismsIsabelle Fernandes, Yolande Bastien, Timothy Wai, et al.
Cell Reports|November 2, 2017
A Targetable EGFR-Dependent Tumor-Initiating Program in Breast CancerPaul Savage, Alexis Blanchet-Cohen, Timothée Revil, et al.
Communications Biology|June 18, 2020
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumorsPaul Savage, Alain Pacis, Hellen Kuasne, et al.
Science Immunology|April 1, 2022
Spatially mapping the immune landscape of melanoma using imaging mass cytometryDan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, et al.
Pageof 2